Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Union Carbide Nuclear Corporation, a subsidiary of Union Carbide, was a primary contractor for the U.S. government, managing critical nuclear research and production facilities such as the Oak Ridge National Laboratory. While its core mission involved uranium enrichment and nuclear materials for defense, the company was a foundational player in the life sciences through its pioneering work in medical radioisotopes. It was responsible for the early production and distribution of isotopes like Iodine-131 and Technetium-99m, which became the backbone of modern nuclear medicine and diagnostic imaging. Additionally, the company's Medical Products Division developed innovative clinical laboratory instrumentation, including the first centrifugal fast analyzers. Although the company's nuclear management contracts ended in 1984 and its parent was later acquired by Dow, its contributions significantly advanced the fields of oncology and radiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Union Carbide Nuclear Corporation.